Henan Lingrui Pharmaceutical Co (SHSE:600285) EPS (Basic) : ¥1.09 (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co EPS (Basic)?

Henan Lingrui Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was ¥0.34. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.09.

Henan Lingrui Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.34. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.09.

Henan Lingrui Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.34. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 1.10.

During the past 12 months, Henan Lingrui Pharmaceutical Co's average EPS without NRIGrowth Rate was 30.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 21.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 16.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 22.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Henan Lingrui Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 61.30% per year. The lowest was -18.40% per year. And the median was 15.10% per year.

Henan Lingrui Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co EPS (Basic) Chart

Henan Lingrui Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.51

0.57

0.65

0.84

1.01

Henan Lingrui Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															0.26	0.30	0.27	0.18	0.34

Henan Lingrui Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Henan Lingrui Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(568.109	-	0)	/	561.373
	=	1.01

Henan Lingrui Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(190.379	-	0)	/	559.937
	=	0.34

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.09

Henan Lingrui Pharmaceutical Co (SHSE:600285) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Henan Lingrui Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Henan Lingrui Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550

Website

http://www.lingrui.com

Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.

Executives

Wu Xi Zhen	Director
Li Jin	Supervisors
Ye Qiang	senior management
Chen Yan	Directors, senior managers
Wu Hui Bin	senior management
Yu Peng	Director
Zhao Zhi Jun	Director
Li Lei	senior management
Feng Guo Xin	Directors, senior managers
Pan Zi Run	Director
Xiong Wei Zheng	Director
Tang Wei	Supervisors
Cheng Jian Jun	Director
Zhang Jun Bing	Director
Xia Hui	senior management

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines